By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Radius Health 

950 Winter Street

Waltham  Massachusetts  02451  U.S.A.
Phone: 617-551-4000 Fax: 617-551-4701


Radius is a science-driven biopharmaceutical company focused on developing new therapeutics for patients with osteoporosis as well as other serious endocrine-mediated diseases.

Radius is committed to the research and development of new therapeutics for the large and underserved osteoporosis market.

Key Statistics

Ownership: Public

Web Site: Radius Health
Symbol: RDUS


Company News
Radius Health (RDUS) Release: Investigational Drug Abaloparatide Reduces The Incidence Of Fractures In Postmenopausal Women With Osteoporosis 10/13/2015 7:40:33 AM
Radius Health (RDUS) Presents Positive Phase 3 Top-Line Data For Investigational Osteoporosis Therapy Abaloparatide At The American Society For Bone And Mineral Research 2015 Annual Meeting 10/12/2015 8:35:52 AM
Radius Health (RDUS) Announces Webcast On Investigational Drug RAD1901, Upcoming Presentations And Investor Day In New York City On November 17th, 2015 9/23/2015 7:32:11 AM
Radius Health (RDUS) Appoints Global Pharmaceutical Leader David P. Snow As Chief Commercial Officer 9/10/2015 7:47:11 AM
Shire (SHPG)’s Plan B if Baxalta Bid Falls Through Includes Radius Health (RDUS), Actelion (ALIOF.PK), and Possibly Ariad (ARIA) 9/8/2015 6:07:42 AM
Radius Health (RDUS) Announced That It Has Appointed Catherine Friedman To The Board Of Directors 8/18/2015 8:17:26 AM
Amgen (AMGN) Vs Radius Health (RDUS): Who Will Dominate Bone Density Market? 8/18/2015 8:06:00 AM
Radius Health (RDUS) To Present At The 35th Annual Canaccord Genuity Growth Conference 8/6/2015 2:57:39 PM
Radius Health (RDUS) Reports Second Quarter 2015 Financial And Operating Results 8/6/2015 1:46:56 PM
Radius Health (RDUS) To Announce Second Quarter 2015 Financial Results, Host Conference Call And Live Webcast On August 6, 2015 7/30/2015 10:50:59 AM